Content uploaded by Tareq Abdhilkadhim Naser Alasadi
Author content
All content in this area was uploaded by Tareq Abdhilkadhim Naser Alasadi on Mar 04, 2021
Content may be subject to copyright.
Johnson and Johnson vaccine
Professor Tareq alasadi
!"
#$ %& '" ()* +
Johnson & Johnson ,-./ ,01 2
3
2 4)5Pfizer Moderna 6
#7 #8 91COVID-19 9)10
. : ;< 6 .
=5) >;<COVID-19
#$Johnson & Johnson <?-)
0 @
3 0A) ) #
Adenovirus %/B)C D$ 'E@ 6 +
. ? F0 ,1 G) H?) IBJ
3D K
3< L)? / 8 H
G< SARS-CoV-2 " M
. -0 C N6J # ? #/J)@ GJ
K< ,? M 8 HDNA
SARS-CoV-2 'E C OM + P-) ;Q
. 0)1 =R? M6 ;
3R S1
C NT + !)0 ? F0 %U<
,B 0 + !*E $ ?
35 '")
. 4)5 4 N1IJohnson & Johnson %2 COVID-19 SV
#? =5) >!)0Pfizer
Moderna COVID-19) #P !*mRNA( / K< SARS-CoV-
2 .#"@/ 0 9@0 M6
) % #?6 #? %0J
(WV ,1J + B?2 ? + ) ;6
%UJ 1
3"7 ?X NH Y5.
. 6Z # ? GJ " ) #@H
+ # / ,) #?J !*0 ;
3R
#?I !)H Y5. WV E BT
. (M6 [H2 'J + 'E MB \ !X7
)2 !*E !$ %U/ %2
. #1 ;Q S 9?) !6< ]EX
Johnson & Johnson + #E >
;Q EJohnson & Johnson L)?
Z !*A
3<QSARS-CoV-2 90 ^
. # J 1/ ( M _5$
#E?/ EQ !*A0 =< #0 `
. . ) < M OU
#$ !*X %EJohnson & Johnson !2 # < ;Q
#E?/ #1 `66 #7 ^
COVID-19 #1 !. #)10
100 ! H.)0 9V* ? ^
a/ #"E0COVID-19 (M6 #1< G)
K KM8 !* ,E7 %E
=5)@ ]X ]? R? #-
) b"EUA (M6 =5)@/ 0
.cX G + M6 %@*
Pd ` + $ ,1 */ 2Q
!*<0 O) #P0 #EJ
) 0 Oe 0/ + SV %2
B? 19 . ;Q E C ")0 ^
. !DI !"V %H A Q 'E
#?& #E)-0 %10 0
'" #-
https://medlineplus.gov/covid19vaccines.ht
ml Z G1")COVID-19
)#7 !"
(B?https://www.cdc.gov/vaccines/covid-
19/index.html Adenoviruses)
( B? #7 !"
https://www.cdc.gov/adenovirus/index.html
Z0 #HfJAMA a # #V 6
JAMA .BR ) %f) %10
%C GR1 #E@? #HX (M6
. E" Y5.) W
3/ ` B?- +
O)/ g1) !* %1 9X
) + #X5. #E"JAMA .) ;Q
.h ,-./ #HX (M6 i G) 7 OEE&
G6h KE& ,E7 J
B).0 #X # XX5)0
. ,@Q + #10J %1E& K. Z0
3)-
3/reprints@jamanetwork.com
!*0 %1 #HX Q j<
: `)k .? G1 2021 .doi: 10.1001 / jama.2021.2927 Xk
: ) l/Q ]X0 cACreech
#X5$ =@ =W)@Altimmune
Horizon Karius Adaptive Premier
Astellas + m #$ ]?0 =W)@ n
#oo #20 g0 ,01
* %2 # cJ)
. pW/k G) G ;< : ;<
: . #$ 1 X0 SVQ %2X Q
Johnson & Johnson ]$ g
Janssen COVID-19 q?/ #" *2Q
#20 `7r0 ,) # #B?
#/J #ooENSEMBLE.
https://www.jnj.com/johnson-johnson-
announce-single-shot-janssen-covid-19-
vaccine-candidate-met-primary-endpoints-
in-interim-analysis-of-its-phase-3 -#7
g1 #001 90 M6 g13 2021 + < P: ,/
| & G ? '" ()*Moderna Pfeizer #f5 #1D. #U@ `A7 +
#7 !" 0/
) B?CDC (Z0 #s0& W
3& )
37
;s/mRNA N?-0 C )/ + !? ,V C
. ; Y5. ? F0 , H)
. 01 oQ Y5. -0 ,6 "?0
;Q -0 C 4 . ;Q 9J0 M6
>Y5. ? F0 M6 , H)
: . ]X0 cA ;s@ Z ;Q G Q
92 0 R K$ Q lE G
JAMA F0 %1 F0 %1
) H #1 #X G1"
COVID19 (,0